Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease

Yıl: 2020 Cilt: 7 Sayı: 3 Sayfa Aralığı: 99 - 104 Metin Dili: İngilizce DOI: 10.5152/eurjrheum.2020.20010 İndeks Tarihi: 21-05-2021

Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease

Öz:
Objective: Behçet’s disease (BD) is a chronic, multisystem disorder that can cause severe morbidity and mortality. Monitoring tools that measure disease activity are required for effective management of BD. We aimed to investigate the association of prognostic nutritional index (PNI) with disease activity in BD.Methods: In this cross-sectional study, we enrolled 88 adult patients with BD and 51 healthy controls. The patients were divided into patients with active and inactive BD according to their disease activ-ities. PNI was calculated using the following formula: 10×serum albumin (g/dL)+0.005×peripheral lymphocyte count (per mm3). To evaluate BD activity, the Behçet Disease Current Activity Form was used. The relations of BD activity with PNI, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, erythrocyte sedimentation rate, and C-reactive protein were investigated. A receiver operator characteristic curve analysis was used to define the optimum cutoff value of PNI for active BD.Results: A total of 48 patients were classified as having active BD and 40 as having inactive BD. Patients with active BD had lower mean PNI than patients with inactive BD and healthy controls (51.8±4.2, 57.4±2.9, and 56.6±3.6, respectively; p<0.001). In multivariate analysis, PNI was the only independent predictor of BD activity (odds ratio, -0.687; 95% confidence interval 0.548-0.861; p=0.001). The opti-mum cutoff of PNI for active BD was 55.35 with 79.2% sensitivity and 77.75% specificity.Conclusion: PNI was significantly associated with BD activity. PNI may be a useful tool for the assess-ment of disease activity in BD.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease. Int J Dermatol 2003; 42: 346-51. [Crossref]
  • 2. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990; 335: 1078-80.
  • 3. International Team for the Revision of the Inter-national Criteria for Behçet's Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014; 28: 338-47. [Crossref]
  • 4. Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet's disease activity index. Rheumatology (Oxford) 2004; 43: 73-8. [Crossref]
  • 5. Melikoglu M, Topkarci Z. Is there a relation between clinical disease activity and acute phase response in Behcet's disease? Int J Dermatol 2014; 53: 250-4. [Crossref]
  • 6. Davatchi F. Behcet's disease. Int J Rheum Dis 2018; 21: 2057-8. [Crossref]
  • 7. Ryu HJ, Seo MR, Choi HJ, Ko KP, Park PW, Baek HJ. Mean platelet volume as a marker for differentiating disease flare from infection in Behcet's disease. Int J Rheum Dis 2018; 21: 1640-5. [Crossref]
  • 8. Alan S, Tuna S, Turkoglu EB. The relation of neu-trophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behcet's syn-drome. Kaohsiung J Med Sci 2015; 31: 626-31. [Crossref]
  • 9. Jeon HG, Choi DK, Sung HH, Jeong BC, Seo SI, Jeon SS, et al. Preoperative Prognostic Nutri-tional Index is a significant predictor of survival in renal cell carcinoma patients undergoing nephrectomy. Ann Surg Oncol 2016; 23: 321-7. [Crossref]
  • 10. Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Ga-kkai Zasshi 1984; 85: 1001-5.
  • 11. Ahn SS, Jung SM, Song JJ, Park YB, Lee SW. Prognostic nutritional index is associated with disease severity and relapse in ANCA-associated vasculitis. Int J Rheum Dis 2019; 22: 797-804. [Crossref]
  • 12. Ahn SS, Jung SM, Song JJ, Park YB, Lee SW. Prognostic nutritional index is correlated with disease activity in patients with systemic lupus erythematosus. Lupus 2018; 27: 1697-705. [Crossref]
  • 13. Correa-Rodriguez M, Pocovi-Gerardino G, Callejas-Rubio JL, Fernandez RR, Martin- Amada M, Cruz-Caparros MG, et al. The Prognostic Nutritional Index and Nutritional Risk Index are as-sociated with disease activity in patients with systemic lupus erythematosus. Nutrients 2019; 11: 638. [Crossref]
  • 14. Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, et al. Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome. Rheumatology (Oxford) 1999; 38: 734-6. [Crossref]
  • 15. Neves FD, Caldas CAM, Medeiros DMD, Moraes JCB, Gonçalves CR. Cross-cultural adaptation of simplified version (s) of Behçet's Disease Current Activity Form (BDCAF) and comparison between two different instruments with Brazilian versions for evaluating Behçet's Disease Activity: BR-BDCAF and BR-BDCAF(s). Revista Brasilei-ra de Reumatologia 2009; 49: 20-31. [Crossref]
  • 16. Fukushima K, Ueno Y, Kawagishi N, Kondo Y, Inoue J, Kakazu E, et al. The nutritional index 'CONUT' is useful for predicting long-term prognosis of patients with end-stage liver diseases. Tohoku J Exp Med 2011; 224: 215-9. [Crossref]
  • 17. Wei GB, Lu YY, Liao RW, Chen QS, Zhang KQ. Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma. Onco Targets Ther 2016; 9: 5955-61. [Crossref]
  • 18. Mohri T, Mohri Y, Shigemori T, Takeuchi K, Itoh Y, Kato T. Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer. World J Surg Oncol 2016; 14: 170. [Crossref]
  • 19. Peters Jr T. Metabolism: Albumin in the body. In: All About Albumin: Biochemistry, Genetics and Medical Applications. Amsterdam: Elsevier; 1996.p.188-250. [Crossref]
  • 20. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth 2000; 85: 599-610. [Crossref]
  • 21. Moshage HJ, Janssen JA, Franssen JH, Hafken-scheid JC, Yap SH. Study of the molecular mechanism of decreased liver synthesis of al-bumin in inflammation. J Clin Invest 1987; 79: 1635-41. [Crossref]
  • 22. Brenner DA, Buck M, Feitelberg SP, Chojkier M. Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Invest 1990; 85: 248-55. [Crossref]
  • 23. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179-86. [Crossref]
  • 24. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986; 78: 1349-54. [Crossref]
  • 25. Adam B, Calikoglu E. Serum interleukin-6, pro-calcitonin and C-reactive protein levels in subjects with active Behcet's disease. J Eur Acad Dermatol Venereol 2004; 18: 318-20. [Crossref]
  • 26. Evereklioglu C, Er H, Turkoz Y, Cekmen M. Se-rum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators Inflamm 2002; 11: 87-93. [Crossref]
  • 27. Levitt DG, Levitt MD. Human serum albumin homeostasis: A new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med 2016; 9: 229-55. [Crossref]
  • 28. Sakane T, Takeno M, Suzuki N, Inaba G. Beh-cet's disease. N Engl J Med 1999; 341: 1284-91. [Crossref]
  • 29. Selders GS, Fetz AE, Radic MZ, Bowlin GL. An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration. Regen Biomater 2017; 4: 55-68. [Crossref]
  • 30. Kam PC, Ferch NI. Apoptosis: Mechanisms and clinical implications. Anaesthesia 2000; 55: 1081-93. [Crossref]
  • 31. Hammad M, Shehata OZ, Abdel-Latif SM, El-Din AMM. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behcet's disease: Which and when to use? Clin Rheumatol 2018; 37: 2811-7. [Crossref]
  • 32. Balkarli A, Kucuk A, Babur H, Erbasan F. Neutrophil/lymphocyte ratio and mean platelet volume in Behcet's disease. Eur Rev Med Phar-macol Sci 2016; 20: 3045-50.
  • 33. Karadağ R, Koca C, Totan Y, Yağcı R, Aydın M, Karadağ AS, et al. Comparison of serum levels of IL-6, IL-8, TNF-α, C reactive protein and heat shock protein 70 in patients with active or inactive Behçet's disease. Turk J Med Sci 2010; 40: 57-62.
  • 34. Aygunduz M, Bavbek N, Ozturk M, Kaftan O, Kosar A, Kirazli S. Serum beta 2-microglobulin reflects disease activity in Behcet's disease. Rheumatol Int 2002; 22: 5-8. [Crossref]
  • 35. Jiang Y, Zang M, Li S. Serum PLR and LMR in Behcet's disease: Can they show the disease activity? Medicine (Baltimore) 2017; 96: e6981. [Crossref]
APA Atas N, Babaoglu H, Demirel E, Çelik B, Bilici Salman R, Satış H, KARADENİZ H, Avanoglu Guler A, HAZNEDAROGLU S, Goker B, TUFAN A, öztürk m (2020). Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. , 99 - 104. 10.5152/eurjrheum.2020.20010
Chicago Atas Nuh,Babaoglu Hakan,Demirel Ertuğrul,Çelik Bülent,Bilici Salman Reyhan,Satış Hasan,KARADENİZ HAZAN,Avanoglu Guler Aslihan,HAZNEDAROGLU SEMINUR,Goker Berna,TUFAN ABDURRAHMAN,öztürk mehmet akif Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. (2020): 99 - 104. 10.5152/eurjrheum.2020.20010
MLA Atas Nuh,Babaoglu Hakan,Demirel Ertuğrul,Çelik Bülent,Bilici Salman Reyhan,Satış Hasan,KARADENİZ HAZAN,Avanoglu Guler Aslihan,HAZNEDAROGLU SEMINUR,Goker Berna,TUFAN ABDURRAHMAN,öztürk mehmet akif Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. , 2020, ss.99 - 104. 10.5152/eurjrheum.2020.20010
AMA Atas N,Babaoglu H,Demirel E,Çelik B,Bilici Salman R,Satış H,KARADENİZ H,Avanoglu Guler A,HAZNEDAROGLU S,Goker B,TUFAN A,öztürk m Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. . 2020; 99 - 104. 10.5152/eurjrheum.2020.20010
Vancouver Atas N,Babaoglu H,Demirel E,Çelik B,Bilici Salman R,Satış H,KARADENİZ H,Avanoglu Guler A,HAZNEDAROGLU S,Goker B,TUFAN A,öztürk m Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. . 2020; 99 - 104. 10.5152/eurjrheum.2020.20010
IEEE Atas N,Babaoglu H,Demirel E,Çelik B,Bilici Salman R,Satış H,KARADENİZ H,Avanoglu Guler A,HAZNEDAROGLU S,Goker B,TUFAN A,öztürk m "Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease." , ss.99 - 104, 2020. 10.5152/eurjrheum.2020.20010
ISNAD Atas, Nuh vd. "Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease". (2020), 99-104. https://doi.org/10.5152/eurjrheum.2020.20010
APA Atas N, Babaoglu H, Demirel E, Çelik B, Bilici Salman R, Satış H, KARADENİZ H, Avanoglu Guler A, HAZNEDAROGLU S, Goker B, TUFAN A, öztürk m (2020). Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. European Journal of Rheumatology, 7(3), 99 - 104. 10.5152/eurjrheum.2020.20010
Chicago Atas Nuh,Babaoglu Hakan,Demirel Ertuğrul,Çelik Bülent,Bilici Salman Reyhan,Satış Hasan,KARADENİZ HAZAN,Avanoglu Guler Aslihan,HAZNEDAROGLU SEMINUR,Goker Berna,TUFAN ABDURRAHMAN,öztürk mehmet akif Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. European Journal of Rheumatology 7, no.3 (2020): 99 - 104. 10.5152/eurjrheum.2020.20010
MLA Atas Nuh,Babaoglu Hakan,Demirel Ertuğrul,Çelik Bülent,Bilici Salman Reyhan,Satış Hasan,KARADENİZ HAZAN,Avanoglu Guler Aslihan,HAZNEDAROGLU SEMINUR,Goker Berna,TUFAN ABDURRAHMAN,öztürk mehmet akif Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. European Journal of Rheumatology, vol.7, no.3, 2020, ss.99 - 104. 10.5152/eurjrheum.2020.20010
AMA Atas N,Babaoglu H,Demirel E,Çelik B,Bilici Salman R,Satış H,KARADENİZ H,Avanoglu Guler A,HAZNEDAROGLU S,Goker B,TUFAN A,öztürk m Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. European Journal of Rheumatology. 2020; 7(3): 99 - 104. 10.5152/eurjrheum.2020.20010
Vancouver Atas N,Babaoglu H,Demirel E,Çelik B,Bilici Salman R,Satış H,KARADENİZ H,Avanoglu Guler A,HAZNEDAROGLU S,Goker B,TUFAN A,öztürk m Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. European Journal of Rheumatology. 2020; 7(3): 99 - 104. 10.5152/eurjrheum.2020.20010
IEEE Atas N,Babaoglu H,Demirel E,Çelik B,Bilici Salman R,Satış H,KARADENİZ H,Avanoglu Guler A,HAZNEDAROGLU S,Goker B,TUFAN A,öztürk m "Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease." European Journal of Rheumatology, 7, ss.99 - 104, 2020. 10.5152/eurjrheum.2020.20010
ISNAD Atas, Nuh vd. "Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease". European Journal of Rheumatology 7/3 (2020), 99-104. https://doi.org/10.5152/eurjrheum.2020.20010